A 52 weeks dupilumab treatment for moderate to severe atopic dermatitis in Korea: long-term efficacy and safety in real world - Concepedia

Concepedia

Publication | Open Access

A 52 weeks dupilumab treatment for moderate to severe atopic dermatitis in Korea: long-term efficacy and safety in real world

DOI Full Paper Access

28

Citations

34

References

2021

Year

Dong Hyek Jang, Seok‐Jae Heo, Hyung Don Kook, Dong Heon Lee, Hye Jung Jung, Mi Yeon Park, Jiyoung Ahn

Scientific Reports

References

	Year	Citations

Page 1